Adherence To Lipid-Lowering Therapy In Patients With Coronary Heart Disease From The State Of Saxony-Anhalt, Germany.

Stephan WaßmuthKatharina RoheFrank Noack Michel NoutsiasHendrik TreedeAxel Schlitt

Published in: Vascular health and risk management (2019)

During follow-up for 3 and 12 months, adherence for statin therapy decreased by 15.7% and for ezetemibe by 46.6%. Here, low adherence to statin therapy was associated with fatal outcome.

Keyphrases

cardiovascular disease
coronary artery disease
glycemic control
type diabetes
mesenchymal stem cells
adipose tissue
skeletal muscle
bone marrow